Evaluation of the monoamine oxidases inhibitory activity of a small series of 5-(azole)methyl oxazolidinones

European Journal of Pharmaceutical Sciences

Volumn 71, Issue , 2015, Pages 56-61

  Phillips, Oludotun A ^a   Sharaf, Leyla H ^a   D'Silva, Roselyn ^a   Udo, Edet E ^a   Benov, Ludmil ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antibacterial activity; Gram positive bacteria; Imidazolyl oxazolidinone; Monoamine oxidases inhibition; N substituted glycinyl oxazolidinone; Triazolyl oxazolidinone

Indexed keywords

5 (1H 1,2,3 TRIAZOLYL)METHYLOXAZOLIDINONE DERIVATIVE; 5 (4 METHYL 1H 1,2,3 TRIAZOLYL)METHYLOXAZOLIDINONE DERIVATIVE; 5 (5 METHYL 1H 1,2,3 TRIAZOLYL)METHYLOXAZOLIDINONE DERIVATIVE; 5 (AZOLE)METHYLOXAZOLIDINONE DERIVATIVE; 5 IMIDAZOYLMETHYLOXAZOLIDINONE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING); ANTIINFECTIVE AGENT; MONOAMINE OXIDASE INHIBITOR; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG POTENCY; DRUG SCREENING; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; OXAZOLIDINONES;

EID: 84923874181     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.02.006     Document Type: Article

References (27)

1. A. Carotti, C. Altomare, M. Catto, C. Gnerre, L. Summo, A. De Marco, S. Rose, P. Jenner, and B. Testa Lipophilicity plays a major role in modulating monoamine oxidase B (MAO-B) inhibition by 7-substituted coumarins Chem. Biodivers. 3 2006 134 149
2. F. Chimenti, R. Fioravanti, A. Bolasco, F. Manna, P. Chimenti, D. Secci, F. Rossi, P. Turini, F. Ortuso, S. Alcaro, and M.C. Cardia Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives Eur. J. Med. Chem. 43 2008 2262 2267
3. F. Chimenti, A. Bolasco, D. Secci, P. Chimenti, A. Granese, S. Carradori, M. Yáñez, F. Orallo, F. Ortuso, and S. Alcaro Investigations on the 2-thiazolyl- hydrazyne scaffold: synthesis and molecular modeling of selective human monoamine oxidase inhibitors Bioorg. Med. Chem. 18 2010 5715 5723
4. N.M. Clark, E.M. Hershberger, M.J. Zervosc, and J.P. Lynch III Antimicrobial resistance among gram-positive organisms in the intensive care unit Curr. Opin. Crit. Care 9 2003 403 412
5. FDA, 2011. Zyvox (linezolid): drug safety communication - serious CNS reactions possible when given to patients taking certain psychiatric medications. In: MedWatch Safety Alerts for Human Medical Products. FDA. Silver Spring, MD. < http://www.fda.gov/drugs/drugsafety/ucm265305.htm >. (accessed 11.11.13).
6. S. Flanagan, K. Bartizal, S.L. Minassian, E. Fang, and P. Prokocimer In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions Antimicrob. Agents Chemother. 57 7 2013 3060 3066
7. C.J. Fowler, and K.F. Tipton Deamination of 5-hydroxytryptamine by both forms of monoamine oxidase in the rat brain J. Neurochem. 38 3 1982 733 736
8. S.I. Hauck, C. Cederberg, A. Doucette, L. Grosser, N.J. Hales, G. Poon, and M.B. Gravestock New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics Bioorg. Med. Chem. Lett. 17 2007 337 340
9. A. Holt, D.F. Sharman, G.B. Baker, and M.M. Palcic A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates Anal. Biochem. 244 1997 384 392
10. T.Z.E. Jones, P. Fleming, C.J. Eyermann, M.B. Gravestock, and R.R. Ramsay Orientation of oxazolidinones in the active site of monoamine oxidase Biochem. Pharmacol. 70 2005 407 416
11. H. Kinemuchi, M. Masato Jinbo, A. Tabata, Y. Toyoshima, Y. Arai, T. Tadano, K. Kisara, and L. Oreland 2-Bromoethylamine, a suicide inhibitor of tissue-bound semicarbazide-sensitive amine oxidase Jpn. J. Pharmacol. 83 2000 164 166
12. K.R. Lawrence, M. Adra, and P.K. Gillman Serotonin toxicity associated with the use of linezolid: a review of postmarketing data Clin. Infect. Dis. 42 2006 1578 1583
13. K.L. Leach, S.J. Brickner, M.C. Noe, and P.F. Miller Linezolid, the first oxazolidinone antibacterial agent Ann. N.Y. Acad. Sci. 1222 2011 49 54
14. F. Leonetti, C. Capaldi, L. Pisani, O. Nicolotti, G. Muncipinto, A. Stefanachi, S. Cellamare, C. Caccia, and A. Carotti Solid-phase synthesis and insights into structure-activity relationships of Safinamide analogues as potent and selective inhibitors of type B monoamine oxidase J. Med. Chem. 50 2007 4909 4916
15. J.V. Meck, D.S. Martin, D.S. D'Aunno, and W.W. Waters Pressor response to intravenous tyramine is a marker of cardiac, but not vascular, adrenergic function J. Cardiovasc. Pharmacol. 41 2003 126 131
16. L. Pisani, R. Farina, O. Nicolotti, D. Gadaleta, R. Soto-Otero, M. Catto, M. Di Braccio, E. Mendez-Alvarez, and A. Carotti In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors Eur. J. Med. Chem. 89 2015 98 105
17. T.-J. Poel, R.C. Thomas, W.J. Adams, P.A. Aristoff, M.R. Barbachyn, and F.E. Boyer Antibacterial oxazolidinones possessing a novel C-5 side chain. (5R)-trans-3-[3-fluoro-4-(1-oxotetrahydrothiopyran-4-yl-phenyl]-2-oxooxazolidinone-5-carboxylic acid amide (PF-00422602-, a new lead compound J. Med. Chem. 50 2007 5886 5889
18. O.A. Phillips, E.E. Udo, A.A.M. Ali, and N. Al-Hassawi Synthesis and antibacterial activity of 5-substituted oxazolidinones Bioorg. Med. Chem. 11 2003 35 41
19. O.A. Phillips, E.E. Udo, A.A.M. Ali, and S.M. Samuel Synthesis and antibacterial activity of new N-linked 5-triazolymethyl oxazolidinones Bioorg. Med. Chem. 13 2005 4113 4123
20. O.A. Phillips, E.E. Udo, A.A.M. Ali, and S.M. Samuel Structure -antibacterial activity of arylcarbonyl- and arylsulfonyl-piperazine 5-triazolylmethyl oxazolidinones Eur. J. Med. Chem. 42 2007 214 225
21. O.A. Phillips, E.E. Udo, M.E. Abdel-Hamid, and R. Varghese Synthesis and antibacterial activities of N-substituted-gylcinyl 1H-1,2,3-triazolyl oxazolidinones Eur. J. Med. Chem. 66 2013 246 257
22. R.R. Ramsay, and M.B. Gravestock Monoamine oxidases: to inhibit or not to inhibit Mini Rev. Med. Chem. 3 2 2003 129 136
23. F. Reck, F. Zhou, M. Girardot, G. Kern, C.J. Eyermann, N.J. Hales, R.R. Ramsay, and M.B. Gravestock Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A J. Med. Chem. 48 2005 499 506
24. F. Reck, F. Zhou, C.J. Eyermann, G. Kern, D. Carcanague, G. Ioannidis, R. Illingworth, G. Poon, and M.B. Gravestock Novel substituted (pyridine-3-yl) phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility J. Med. Chem. 50 2007 4868 4881
25. L. Santana, H. González-Díaz, E. Quezada, E. Uriarte, M. Yánez, D. Viña, and F. Orallo Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors J. Med. Chem. 51 2008 6740 6751
26. K.J. Shaw, and M.R. Barbachyn The oxazolidinones: past, present and future Ann. N.Y. Acad. Sci. 1241 2011 48 70
27. M.H. Wilcox Update on linezolid: the first oxazolidinone antibiotic Expert. Opin. Pharmacother. 6 2005 2315 2326